drugset / Trial / NCT00903786
A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this trial is to investigate the safety and tolerability of perampanel in long- term treatment in the patients with refractory partial epilepsy (uncontrolled with other anti-epileptic drugs) who completed Week 10 of Phase II Study E2007-J081-231 study.
Timeline
- Start
- 2009-06-17
- Primary completion
- 2016-08-08
- Completion
- 2016-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Perampanel | Small molecule | 2 mg | Oral |
| Subject | Perampanel | Small molecule | 12 mg | Oral |